• Health & Medicine

A quiet epidemic - men's risk of oesophageal cancer is triple women's risk

Men are almost three times more likely to get oesophageal cancer than women – one of the biggest gender gaps in cancer rates – according to figures released from Cancer Research UK. Men are almost three times more likely to get oesophageal cancer than women – one of the biggest gender gaps in cancer rates – according to figures released from Cancer Research UK.

18 June 2013

• Health & Medicine

HPV testing could cut cervical cancers by a third

Testing women for HPV first to detect abnormal cells in the cervix, could prevent around 600 cases of cervical cancer a year in England. Testing women for HPV first to detect abnormal cells in the cervix, could prevent around 600 cases of cervical cancer a year in England.

14 June 2013

• Science & Technology

Shape-shifting cells help skin cancer spread

Scientists have discovered genes that control shape changes in melanoma skin cancer cells, allowing them to wriggle free and spread around the body. Scientists have discovered genes that control shape changes in melanoma skin cancer cells, allowing them to wriggle free and spread around the body.

9 June 2013

DNA sequencing reveals mucosal melanoma's bullseye

Scientists have found a molecular 'bullseye' for a rare form of melanoma, opening up opportunities for new targeted treatment, according to new research being published in the Journal of Pathology. Scientists have found a molecular 'bullseye' for a rare form of melanoma, opening up opportunities for new targeted treatment, according to new research being published in the Journal of Pathology.

7 June 2013

Cancer Research UK and CRT collaborate with Abcodia to discover and develop tests for early diagnosis of cancer

CANCER RESEARCH UK and its commercial arm, Cancer Research Technology (CRT), have joined forces with Abcodia, the biomarker validation company with a focus on cancer screening, to develop new blood tests to detect a range of cancers when they are still at a very early stage. CANCER RESEARCH UK and its commercial arm, Cancer Research Technology (CRT), have joined forces with Abcodia, the biomarker validation company with a focus on cancer screening, to develop new blood tests to detect a range of cancers when they are still at a very early stage.

6 June 2013

Wobbling molecules help scientists study brain tumours in children

Advances in cancer imaging are helping our scientists take a closer look at childhood brain tumours, improving diagnosis and treatment selection in the future. Advances in cancer imaging are helping our scientists take a closer look at childhood brain tumours, improving diagnosis and treatment selection in the future.

5 June 2013

• Health & Medicine

Study confirms long term benefits of tamoxifen

Taking tamoxifen for 10 rather than five years halves the risk of women dying from the most common kind of breast cancer. Taking tamoxifen for 10 rather than five years halves the risk of women dying from the most common kind of breast cancer.

2 June 2013

Experts call for breast cancer trials aimed at younger patients

A lack of clinical trials aimed specifically at younger breast cancer patients could be partly to blame for their poorer survival rates. A lack of clinical trials aimed specifically at younger breast cancer patients could be partly to blame for their poorer survival rates.

31 May 2013

Cancer Research UK launches trial for potential new drug to block cancer cells' energy supply

CANCER RESEARCH UK’s Drug Development Office (DDO) has launched a new clinical trial of a brand new type of experimental drug to treat a range of cancers. CANCER RESEARCH UK’s Drug Development Office (DDO) has launched a new clinical trial of a brand new type of experimental drug to treat a range of cancers.

31 May 2013

• Health & Medicine

Non-Hodgkin lymphoma survival doubles since early 1970s

More than half of patients diagnosed with Non-Hodgkin Lymphoma (NHL) are now surviving the disease thanks to improved diagnosis and treatment, according to a new report from Cancer Research UK. More than half of patients diagnosed with Non-Hodgkin Lymphoma (NHL) are now surviving the disease thanks to improved diagnosis and treatment, according to a new report from Cancer Research UK.

23 May 2013

Beta-blockers may boost chemo effect in childhood cancer

Beta-blockers, normally used for high blood pressure, could enhance the effectiveness of chemotherapies in treating neuroblastoma, a type of children's cancer, according to a new study published in the British Journal of Cancer. Beta-blockers, normally used for high blood pressure, could enhance the effectiveness of chemotherapies in treating neuroblastoma, a type of children's cancer, according to a new study published in the British Journal of Cancer.

22 May 2013

• Health & Medicine

Cancer survivors need more support to stop smoking and drinking

Cancer survivors are no more likely to stop smoking, cut down on alcohol, or exercise more often than the general population, according to new research published in the British Journal of Cancer today (Wednesday). Cancer survivors are no more likely to stop smoking, cut down on alcohol, or exercise more often than the general population, according to new research published in the British Journal of Cancer today (Wednesday).

22 May 2013